(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer

PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito, Ana E., Santos, Allan, Sasse, André Deeke, Cabello, Cesar, Oliveira, Paulo, Mosci, Camila, Souza, Tiago, Amorim, Barbara, Lima, Mariana, Ramos, Celso D., Etchebehere, Elba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482633/
https://www.ncbi.nlm.nih.gov/pubmed/28415595
http://dx.doi.org/10.18632/oncotarget.16418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482633/
https://www.ncbi.nlm.nih.gov/pubmed/28415595
http://dx.doi.org/10.18632/oncotarget.16418

Ejemplares similares